In this study, we investigated the potential involvement of TNFSF9 in reperfusion injury associated with ferroptosis in acute ischaemic stroke patients, mouse models and BV2 microglia. We first examined TNFSF9 changes in peripheral blood from stroke patients with successful reperfusion, and constructed oxygen–glucose deprivation–reperfusion (OGD‐R) on BV2 microglia, oxygen–glucose deprivation for 6 h followed by reoxygenation and re‐glucose for 24 h, and appropriate over‐expression or knockdown of TNFSF9 manipulation on BV2 cells and found that in the case of BV2 cells encountering OGD‐R over‐expression of TNFSF9 resulted in increased BV2 apoptosis. Still, the knockdown of TNFSF9 ameliorated apoptosis and ferroptosis. In an in vivo experiment, we constructed TNFSF9 over‐expression or knockout mice by intracerebral injection of TNFSF9‐OE or sh‐TNFSF9 adenovirus. We performed the middle cerebral artery occlusion (MCAO) model on day four, 24 h after ligation of the proximal artery, for half an hour to recanalize. As luck would have it, over‐expression of TNFSF9 resulted in increased brain infarct volumes, neurological function scores and abnormalities in TNFSF9‐related TRAF1 and ferroptosis‐related pathways, but knockdown of TNFSF9 improved brain infarcts in mice as well as reversing TNFSF9‐related signalling pathways. In conclusion, our data provide the first evidence that TNFSF9 triggers microglia activation by activating the ferroptosis signalling pathway following ischaemic stroke, leading to brain injury and neurological deficits.